Report overview
Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.
This report aims to provide a comprehensive presentation of the global market for Diabetes Management Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Management Devices. This report contains market size and forecasts of Diabetes Management Devices in global, including the following market information:
Global Diabetes Management Devices Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Management Devices market was valued at US$ 41190 million in 2022 and is projected to reach US$ 64850 million by 2029, at a CAGR of 6.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Diabetes is a chronic disease and is increasing at a rapid pace across the world. It is that state in the body when the pancreas cannot produce sufficient insulin. Increasing blood sugar level can be a threat and can cause severe damage to the body. The study identifies rising global burden of diabetes as one of the primary growth factors for diabetes management devices market. Factors responsible for increase in diabetic population include obesity, smoking, sedentary lifestyle, and growing urbanization. Older people above 65 years are more prone to diabetes. Countries such as China and India have higher diabetic people due to the increase in obesity and urbanization. Owing to the increase in diabetic population across the world, there is increase in adoption of diabetes management devices.
We surveyed the Diabetes Management Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Management Devices Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Management Devices Market Segment Percentages, by Type, 2022 (%)
Blood Glucose Monitoring Device
Insulin Delivery Systems
Global Diabetes Management Devices Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Management Devices Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Diabetes Management Devices Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Management Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Management Devices revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Management Devices revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Dexcom
Roche
Lifescan
Medtronic
Terumo
B. Braun Melsungen
BD
Ascensia (Bayer)
Senseonics Holdings
Johnson & Johnson
Eli Lilly
Novo Nordisk
Sanofi
Ypsomed Holding
GlySens Incorporated
Meiqi Medical Equipment
San Meditech
All Medicus
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Management Devices, market overview.
Chapter 2: Global Diabetes Management Devices market size in revenue.
Chapter 3: Detailed analysis of Diabetes Management Devices company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Management Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
